ATE316779T1 - Implantate zur gesteuerten freisetzung von pharmazeutischen wirkstoffen und verfahren zur herstellung - Google Patents

Implantate zur gesteuerten freisetzung von pharmazeutischen wirkstoffen und verfahren zur herstellung

Info

Publication number
ATE316779T1
ATE316779T1 AT98930779T AT98930779T ATE316779T1 AT E316779 T1 ATE316779 T1 AT E316779T1 AT 98930779 T AT98930779 T AT 98930779T AT 98930779 T AT98930779 T AT 98930779T AT E316779 T1 ATE316779 T1 AT E316779T1
Authority
AT
Austria
Prior art keywords
production
controlled release
implants
core
active ingredients
Prior art date
Application number
AT98930779T
Other languages
English (en)
Inventor
Alexandra Rothen-Weinhold
Robert Gurny
Piero Orsolini
Frederic Heimgartner
Original Assignee
Debio Rech Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debio Rech Pharma Sa filed Critical Debio Rech Pharma Sa
Application granted granted Critical
Publication of ATE316779T1 publication Critical patent/ATE316779T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
AT98930779T 1997-06-04 1998-06-02 Implantate zur gesteuerten freisetzung von pharmazeutischen wirkstoffen und verfahren zur herstellung ATE316779T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9706874 1997-06-04

Publications (1)

Publication Number Publication Date
ATE316779T1 true ATE316779T1 (de) 2006-02-15

Family

ID=9507573

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98930779T ATE316779T1 (de) 1997-06-04 1998-06-02 Implantate zur gesteuerten freisetzung von pharmazeutischen wirkstoffen und verfahren zur herstellung

Country Status (10)

Country Link
US (1) US6319512B1 (de)
EP (1) EP1001743B1 (de)
JP (1) JP2002511075A (de)
AT (1) ATE316779T1 (de)
AU (1) AU742372B2 (de)
CA (1) CA2291659A1 (de)
DE (1) DE69833375D1 (de)
IL (1) IL133105A (de)
NO (1) NO995908D0 (de)
WO (1) WO1998055101A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6767550B1 (en) * 2000-06-30 2004-07-27 Berkeley Advanced Biomaterials, Inc. Hydroxyapatite based drug delivery implant for cancer treatment
AU2001296770A1 (en) * 2000-10-06 2002-04-15 Durect Corporation Devices and methods for management of inflammation
US7666445B2 (en) * 2000-10-20 2010-02-23 The Trustees Of The University Of Pennsylvania Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use
AU2002324447B2 (en) 2001-06-22 2006-06-29 Durect Corporation Zero-order prolonged release coaxial implants
KR20040036928A (ko) * 2001-08-31 2004-05-03 쉐링 오와이 약물 전달 시스템
DE10237572A1 (de) * 2002-08-13 2004-02-26 Biotronik Meß- und Therapiegeräte GmbH & Co. Ingenieurbüro Berlin Stent mit polymerer Beschichtung
SE0202619D0 (sv) * 2002-09-05 2002-09-05 Fredrik Nederberg New Polymers and Applications
AU2005206143B2 (en) * 2004-01-12 2010-12-16 The Trustees Of The University Of Pennsylvania Long-term delivery formulations and methods of use thereof
US8329203B2 (en) * 2004-01-12 2012-12-11 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
US8221778B2 (en) 2005-01-12 2012-07-17 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
US8119154B2 (en) * 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
WO2005107715A1 (en) * 2004-05-11 2005-11-17 Debio Recherche Pharmaceutique S.A. Implantable composition
US8541028B2 (en) 2004-08-04 2013-09-24 Evonik Corporation Methods for manufacturing delivery devices and devices thereof
MX362908B (es) * 2005-07-18 2019-02-21 Univ Pennsylvania Implantes que contienen fármacos y métodos de uso de los mismos.
CA2631811C (en) * 2005-12-22 2017-06-20 Novartis Ag Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers
SI2010184T1 (sl) * 2006-04-06 2013-05-31 Nupathe Inc. Implantati za zdravljenje stanj, povezanih z dopaminom
AU2007248949B2 (en) * 2006-05-09 2010-04-08 Astrazeneca Ab Parenteral formulation comprising proton pump inhibitor sterilized in its final container by ionizing radiation
ITMI20061538A1 (it) * 2006-08-02 2008-02-03 Mediolanum Pharmaceuticals Ltd Impianti sottocutanei in grado di rilasciare il principio attivo per un periodo prolungato di tempo
US8728528B2 (en) 2007-12-20 2014-05-20 Evonik Corporation Process for preparing microparticles having a low residual solvent volume
WO2010088697A2 (en) * 2009-02-02 2010-08-05 Medtronic, Inc. Antimicrobial accessory for an implantable medical device
EP2246063A1 (de) 2009-04-29 2010-11-03 Ipsen Pharma S.A.S. GnRH Analoge enthaltende Retardformulierungen
US20100278895A1 (en) * 2009-04-30 2010-11-04 Medtronic, Inc. Antioxidants and antimicrobial accessories including antioxidants
BR112012002341A8 (pt) 2009-08-06 2017-10-10 Koninklijke Philips Electronics Nv Semente radioativa para uso na terapia oncológica e método de terapia oncológica
JP2013505251A (ja) * 2009-09-17 2013-02-14 エボニック デグサ コーポレイション 放出プロファイルが異なるインプラントデバイス並びにその製造及び使用方法
US8911427B2 (en) * 2010-12-28 2014-12-16 Medtronic, Inc. Therapeutic agent reservoir delivery system

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2041377B (en) * 1979-01-22 1983-09-28 Woodroof Lab Inc Bio compatible and blood compatible materials and methods
JPH0778017B2 (ja) * 1985-12-28 1995-08-23 住友製薬株式会社 パルス的かつ持続放出性製剤
US4894231A (en) 1987-07-28 1990-01-16 Biomeasure, Inc. Therapeutic agent delivery system
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
KR920703028A (ko) * 1990-01-30 1992-12-17 에프.지.엠.헤르만스 벽으로 둘러싸이고 하나이상의 활성물질로 전체적으로 또는 부분적으로 충전된 중공공간을 포함하는 활성물질의 배출량을 조절하는 제품
US5378475A (en) * 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
CA2141459A1 (en) * 1992-07-31 1994-02-17 Richard Yu Controlled release implants
JP3720386B2 (ja) 1993-12-27 2005-11-24 住友製薬株式会社 薬物放出制御製剤
AUPM897594A0 (en) * 1994-10-25 1994-11-17 Daratech Pty Ltd Controlled release container
ES2246004T3 (es) * 1996-02-02 2006-02-01 Alza Corporation Liberacion prolongada de un agente activo usando un sistema implantable.

Also Published As

Publication number Publication date
JP2002511075A (ja) 2002-04-09
NO995908L (no) 1999-12-02
NO995908D0 (no) 1999-12-02
IL133105A (en) 2004-09-27
EP1001743A1 (de) 2000-05-24
US6319512B1 (en) 2001-11-20
EP1001743B1 (de) 2006-02-01
CA2291659A1 (fr) 1998-12-10
IL133105A0 (en) 2001-03-19
WO1998055101A1 (fr) 1998-12-10
DE69833375D1 (de) 2006-04-13
AU8109398A (en) 1998-12-21
AU742372B2 (en) 2002-01-03

Similar Documents

Publication Publication Date Title
ATE316779T1 (de) Implantate zur gesteuerten freisetzung von pharmazeutischen wirkstoffen und verfahren zur herstellung
DE59610355D1 (de) Medizinisches implantat
CA2158638A1 (en) A Composition and a Method for Tissue Augmentation
ES2184895T3 (es) Sistema no polimerico de administracion con liberacion retardada.
NO952131L (no) Fremgangsmåte for behandling av et kirurgisk metallimplantat
ATE198982T1 (de) Verfahren zur herstellung von festen pharmazeutischen dosierungsformen hydrophobischen substanzen
DE59810581D1 (de) Verfahren zur Herstellung feinstrukturierter medizintechnischer Implantate
ATE243720T1 (de) Hydrogelbildende, selbst-solvatisierende, absorbierbare polyestercopolymere sowie verfahren zu deren verwendung
PT88945A (pt) Processo para a preparacao de formas de dosagem farmaceuticas de libertacao controlada contendo um antagonista do calcio, tal como cloridrato de diltiazem
IS4083A (is) Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja
NO995843D0 (no) Farmasöytisk preparat omfattende vWF-propeptid
DE3682811D1 (de) Pharmazeutische zusammensetzung zur heilung und verhuetung kardiovaskularer krankheiten und verfahren zu ihrer herstellung.
UA26204C2 (uk) Спосіб запобігаhhя деградації кісткового протеза
DE59611383D1 (de) Darreichungsform zur applikation von pharmazeutischen wirkstoffen und hilfsstoffen und verfahren zur herstellung derselben
FR2845289B1 (fr) Spheroides, procede de preparation et compositions pharmaceutiques.
DE69719930D1 (de) Verfahren zur Herstellung von medizinischen Pflastern zur perkutanen Verabreichung, und Vorrichtung dafür
DE69804766D1 (de) Isoflavonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
AP9801416A0 (en) Method Of treating a plant disease.
DE69410042D1 (de) Esterverbindung, Wirkstoff zur Kontrolle von schädlichen Parasiten diese enthaltend als Wirksubstanz, Zwischenverbindung zur Herstellung der Esterverbindung, sowie Verfahren zur Herstellung der Zwischenverbindung
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
DK0704219T3 (da) Anvendelse af faktor for osteoblastisk celledeling
ATE295731T1 (de) Olanzapine zur behandlung von drogenmissbrauch
FR2736548B1 (fr) Utilisation d'un retinoide pour la preparation d'un medicament antibacterien et methode de traitement cosmetique
UA9522A (uk) Спосіб лікування аутоімунного тиреоідиту
WO2001095916A3 (de) Anticholestatisches arzneimittel

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties